Efavirenz contraindications: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Efavirenz}} {{CMG}}; {{AE}} {{AZ}} ==References== {{Reflist}} {{FDA}} Category:Antibiotics Category:Wikinfect")
 
mNo edit summary
 
(3 intermediate revisions by one other user not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{AZ}}
{{CMG}}; {{AE}} {{AZ}}


==Contraindications==


===Hypersensitivity===


SUSTIVA is contraindicated in patients with previously demonstrated clinically significant [[hypersensitivity]] (eg, [[Stevens-Johnson syndrome]], [[erythema multiforme]], or toxic skin eruptions) to any of the components of this product.
===Contraindicated Drugs===
For some drugs, competition for [[CYP3A]] by efavirenz could result in inhibition of their metabolism and create the potential for serious and/or life-threatening adverse reactions (eg, cardiac [[arrhythmia]]s, prolonged [[sedation]], or [[respiratory depression]]). Drugs that are contraindicated with SUSTIVA are listed in Table 2.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = SUSTIVA (EFAVIRENZ) CAPSULE, GELATIN COATED SUSTIVA (EFAVIRENZ) CAPSULE, GELATIN COATED SUSTIVA (EFAVIRENZ) TABLET, FILM COATED [BRISTOL-MYERS SQUIBB PHARMA COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32d6371e-ba56-4294-b732-6d43627c5c47 | publisher =  | date =  | accessdate =  }}</ref>
{|
|[[File:Contrasustiva.JPG|800px|thumb]]
|}


==References==
==References==

Latest revision as of 06:17, 5 January 2014

Efavirenz
SUSTIVA® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Contraindications

Hypersensitivity

SUSTIVA is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (eg, Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of this product.

Contraindicated Drugs

For some drugs, competition for CYP3A by efavirenz could result in inhibition of their metabolism and create the potential for serious and/or life-threatening adverse reactions (eg, cardiac arrhythmias, prolonged sedation, or respiratory depression). Drugs that are contraindicated with SUSTIVA are listed in Table 2.[1]

References

  1. "SUSTIVA (EFAVIRENZ) CAPSULE, GELATIN COATED SUSTIVA (EFAVIRENZ) CAPSULE, GELATIN COATED SUSTIVA (EFAVIRENZ) TABLET, FILM COATED [BRISTOL-MYERS SQUIBB PHARMA COMPANY]".

Adapted from the FDA Package Insert.